Mobile

A randomised, placebo-controlled, incomplete block, three-way cross-over study to evaluate the effect of treatment with repeat inhaled doses of GW870086X on the allergen-induced early and late asthmat...

Mise à jour : Il y a 4 ans
Référence : EUCTR2007-005791-14

A randomised, placebo-controlled, incomplete block, three-way cross-over study to evaluate the effect of treatment with repeat inhaled doses of GW870086X on the allergen-induced early and late asthmatic response in subjects with mild asthma

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To evaluate the effect of treatment with repeat inhaled doses of GW870086X once daily for 13 days on the late asthmatic response (LAR) to inhaled allergen in mild asthmatic subjects compared with placebo

Critère d'inclusion

  • Mild Asthma

Liens